Literature DB >> 30971426

Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.

Clémence Richetta1, Sylvain Thierry1, Eloise Thierry1, Paul Lesbats2, Delphine Lapaillerie2, Soundasse Munir1, Frédéric Subra1, Hervé Leh1, Eric Deprez1, Vincent Parissi2, Olivier Delelis3.   

Abstract

Integration of the HIV-1 DNA into the host genome is essential for viral replication and is catalyzed by the retroviral integrase. To date, the only substrate described to be involved in this critical reaction is the linear viral DNA produced in reverse transcription. However, during HIV-1 infection, two-long terminal repeat DNA circles (2-LTRcs) are also generated through the ligation of the viral DNA ends by the host cell's nonhomologous DNA end-joining pathway. These DNAs contain all the genetic information required for viral replication, but their role in HIV-1's life cycle remains unknown. We previously showed that both linear and circular DNA fragments containing the 2-LTR palindrome junction can be efficiently cleaved in vitro by recombinant integrases, leading to the formation of linear 3'-processed-like DNA. In this report, using in vitro experiments with purified proteins and DNAs along with DNA endonuclease and in vivo integration assays, we show that this circularized genome can also be efficiently used as a substrate in HIV-1 integrase-mediated integration both in vitro and in eukaryotic cells. Notably, we demonstrate that the palindrome cleavage occurs via a two-step mechanism leading to a blunt-ended DNA product, followed by a classical 3'-processing reaction; this cleavage leads to integrase-dependent integration, highlighted by a 5-bp duplication of the host genome. Our results suggest that 2-LTRc may constitute a reserve supply of HIV-1 genomes for proviral integration.
© 2019 Richetta et al.

Entities:  

Keywords:  2-LTR circles; HIV-1 integration; circular DNA; human immunodeficiency virus (HIV); infectious disease; integrase; palindromic sequence; retrovirus; strand-transfer inhibitors; viral replication

Mesh:

Substances:

Year:  2019        PMID: 30971426      PMCID: PMC6527176          DOI: 10.1074/jbc.RA118.006755

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.

Authors:  A Engelman; K Mizuuchi; R Craigie
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

Review 2.  Emerging pharmacology: inhibitors of human immunodeficiency virus integration.

Authors:  Daria Hazuda; Marian Iwamoto; Larissa Wenning
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

3.  Roles of host cell factors in circularization of retroviral dna.

Authors:  Jennifer M Kilzer; Travis Stracker; Brett Beitzel; Katheryn Meek; Matthew Weitzman; Frederic D Bushman
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

4.  The DNA repair genes XPB and XPD defend cells from retroviral infection.

Authors:  Kristine Yoder; Alain Sarasin; Kenneth Kraemer; Michael McIlhatton; Frederic Bushman; Richard Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

5.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

6.  G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance.

Authors:  Soundasse Munir; Eloise Thierry; Isabelle Malet; Frédéric Subra; Vincent Calvez; Anne-Geneviève Marcelin; Eric Deprez; Olivier Delelis
Journal:  J Antimicrob Chemother       Date:  2014-11-20       Impact factor: 5.790

Review 7.  The role of unintegrated DNA in HIV infection.

Authors:  Richard D Sloan; Mark A Wainberg
Journal:  Retrovirology       Date:  2011-07-01       Impact factor: 4.602

8.  Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration.

Authors:  Sylvain Thierry; Soundasse Munir; Eloïse Thierry; Frédéric Subra; Hervé Leh; Alessia Zamborlini; Dyana Saenz; David N Levy; Paul Lesbats; Ali Saïb; Vincent Parissi; Eric Poeschla; Eric Deprez; Olivier Delelis
Journal:  Retrovirology       Date:  2015-03-12       Impact factor: 4.602

9.  In vitro initial attachment of HIV-1 integrase to viral ends: control of the DNA specific interaction by the oligomerization state.

Authors:  P Lesbats; M Métifiot; C Calmels; S Baranova; G Nevinsky; M L Andreola; V Parissi
Journal:  Nucleic Acids Res       Date:  2008-11-05       Impact factor: 16.971

10.  Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase.

Authors:  Olivier Delelis; Vincent Parissi; Hervé Leh; Gladys Mbemba; Caroline Petit; Pierre Sonigo; Eric Deprez; Jean-François Mouscadet
Journal:  PLoS One       Date:  2007-07-11       Impact factor: 3.240

View more
  2 in total

1.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

2.  Exploring histone loading on HIV DNA reveals a dynamic nucleosome positioning between unintegrated and integrated viral genome.

Authors:  Shinichi Machida; David Depierre; Heng-Chang Chen; Suzie Thenin-Houssier; Gaël Petitjean; Cecile M Doyen; Motoki Takaku; Olivier Cuvier; Monsef Benkirane
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.